We are an oncology-focused biopharmaceutical company dedicated to improving
the lives of cancer patients. We have in-licensed and are currently developing
three product candidates, rolapitant, niraparib and TSR-011. We intend to
continue to leverage the experience and competencies of our senior management
team to identify, acquire, develop and commercialize cancer therapeutics and
oncology supportive care products that are safer and more effective than
existing treatments. Upon successful development and regulatory approval of
any of our product candidates we intend to make them available to cancer
patients in North America, Europe and China through our own commercialization
efforts and to establish a network of licensees and distributors in other
We were incorporated under the laws of the State of Delaware in March 2010.
Our principal executive offices are located at 1000 Winter Street, Suite 3300,
Waltham, Massachusetts 02451, and our telephone number is (339) 970-0900. Our
website address is www.tesarobio.com.